These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7073838)

  • 1. [Characteristics of nonspecific resistance factors in laryngeal neoplasms].
    Zabirov RA
    Vestn Otorinolaringol; 1982; (1):51-2. PubMed ID: 7073838
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological status of laryngeal cancer patients and the problems of nonspecific immunotherapy].
    Nasretdinov TKh; Gorodilova VV; Pogosov VS; Akopian RG
    Vestn Otorinolaringol; 1981; (4):56-61. PubMed ID: 7303375
    [No Abstract]   [Full Text] [Related]  

  • 3. [Indices of nonspecific resistance in laryngeal cancer patients in the late period after combined treatment].
    Zabirov RA
    Vestn Otorinolaringol; 1984; (5):40-2. PubMed ID: 6495497
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nonspecific factors of immunity in patients with cancer of the larynx].
    Kitsmaniuk ZD; Smol'ianinov ES; Choĭnzonov EL
    Vestn Otorinolaringol; 1984; (3):41-4. PubMed ID: 6730151
    [No Abstract]   [Full Text] [Related]  

  • 5. [Natural resistance factors in laryngeal cancer].
    Pogosov VS; Nasretdinov TKh
    Vestn Otorinolaringol; 1980; (6):67-71. PubMed ID: 7456241
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immune alterations in patients with laryngeal cancer at different stages].
    Khrustaleva EV
    Vestn Otorinolaringol; 2005; (4):22-4. PubMed ID: 16091717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKG2D ligands expression and NKG2D-mediated cytotoxicity in human laryngeal squamous carcinoma cells.
    Chen XM; Xu XQ; Sun K; Hallett WH; Zhao JD; Zhang DL
    Scand J Immunol; 2008 May; 67(5):441-7. PubMed ID: 18312485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inmunohistochimic expresion of p53 protein and TTS prognostic value in the larynx cancer].
    García Lozano MC; Orradre Romero JL; Caro García M; Sáez del Castillo AI; Piris Pinilla MA
    An Otorrinolaringol Ibero Am; 2004; 31(6):515-29. PubMed ID: 15663083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the immune response in patients with laryngeal cancer using specific and nonspecific tests: initial results of a follow-up in 80 cases].
    Cortesina G; Cavallo GP; Bussi M; Beatrice F; Di Fortunato V; Poggio E; Rendine S; Barioglio MG; Sartoris A
    Acta Otorhinolaryngol Ital; 1985; 5(1):7-18. PubMed ID: 4036592
    [No Abstract]   [Full Text] [Related]  

  • 10. TNM staging of laryngeal cancer.
    Talaat M
    Ann Otol Rhinol Laryngol; 1993 Jan; 102(1 Pt 1):78. PubMed ID: 8420476
    [No Abstract]   [Full Text] [Related]  

  • 11. [Indicators of resistance to infection in children with respiratory papillomatosis].
    Ashurov ZM; Savitskaia KI; Rusanova EV; Shevtsov VV; Vozhagov VV; Musatenko LIu
    Vestn Otorinolaringol; 1996; (4):28-31. PubMed ID: 8966874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of magnetic resonance imaging in staging of laryngeal cancer].
    Li G; Xu Y; Zheng Y
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Aug; 33(4):240-1. PubMed ID: 11717894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [State of anti-infection immunity in laryngeal cancer patients undergoing combined and radical radiation treatment].
    Kochetkova VA; Demidov VP; Poluéktova NA; Bitiutskiĭ PG; Trofimov EI
    Vestn Otorinolaringol; 1980; (5):45-9. PubMed ID: 7414826
    [No Abstract]   [Full Text] [Related]  

  • 14. [Histologic studies on the problem of endogenous bodily defense in laryngeal carcinoma].
    Zechner G
    Monatsschr Ohrenheilkd Laryngorhinol; 1965; 99(8):420-4. PubMed ID: 5882588
    [No Abstract]   [Full Text] [Related]  

  • 15. [Additions to the TNM classification of pharyngeal and laryngeal tumors].
    Stastný B; Kroslák M; Chodúrová A
    Cesk Otolaryngol; 1980 Oct; 29(5):257-65. PubMed ID: 7448903
    [No Abstract]   [Full Text] [Related]  

  • 16. Laryngeal preservation in the era of chemoradiation: limitations of the current AJCC staging system.
    Holsinger FC; Diaz EM
    Head Neck; 2006 Dec; 28(12):1058-60. PubMed ID: 17099907
    [No Abstract]   [Full Text] [Related]  

  • 17. [The symptom complex of clinical and laboratory manifestations of laryngeal cancer associated with a high blood level of natural killer cells].
    Khrustaleva EV
    Vestn Otorinolaringol; 2006; (1):8-12. PubMed ID: 16482002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced laryngeal carcinoma: surgical and non-surgical management options.
    Jalisi M; Jalisi S
    Otolaryngol Clin North Am; 2005 Feb; 38(1):47-57, viii. PubMed ID: 15649498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathology and pathologic prognostic indicators.
    Cappellari JO
    Otolaryngol Clin North Am; 1997 Apr; 30(2):251-68. PubMed ID: 9052669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on localization of laryngeal carcinoma associated antigen by immunoelectromicroscopy].
    Ni Z; Yi J; Xu Y
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Feb; 34(1):41-2. PubMed ID: 12764796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.